Who
Matthew Norkunas
Director
Company insider
Files Form 4 as: Director, Obsidian Therapeutics; Chief Financial Officer, Generation Bio Co.
In numbers
- Trades disclosed
- 63
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 22 Jul 2020
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | OBX Obsidian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,653 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | OBX Obsidian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,653 at $0.00 | filing |
| 15 Oct 2024filed 17 Oct 2024 | Generation Bio Cooption or derivative | SEC FORM 4 Code M | —1,674 at $0.00 | filing |
| 15 Oct 2024filed 17 Oct 2024 | Generation Bio Cooption or derivative | SEC FORM 4 Code M | —1,673 at $0.00 | filing |
| 15 Oct 2024filed 17 Oct 2024 | Generation Bio Co | SEC FORM 4 Code M | —1,674 | filing |
| 15 Oct 2024filed 17 Oct 2024 | Generation Bio Co | SEC FORM 4 Code F | $1,191492 at $2.42 | filing |
| 15 Oct 2024filed 17 Oct 2024 | Generation Bio Co | SEC FORM 4 Code M | —1,673 | filing |
| 15 Oct 2024filed 17 Oct 2024 | Generation Bio Co | SEC FORM 4 Code F | $1,191492 at $2.42 | filing |
| 15 Jul 2024filed 17 Jul 2024 | Generation Bio Cooption or derivative | SEC FORM 4 Code M | —1,674 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | Generation Bio Cooption or derivative | SEC FORM 4 Code M | —1,673 at $0.00 | filing |
| 15 Jul 2024filed 17 Jul 2024 | Generation Bio Co | SEC FORM 4 Code M | —1,674 | filing |
| 15 Jul 2024filed 17 Jul 2024 | Generation Bio Co | SEC FORM 4 Code F | $1,442492 at $2.93 | filing |
| 15 Jul 2024filed 17 Jul 2024 | Generation Bio Co | SEC FORM 4 Code M | —1,673 | filing |
| 15 Jul 2024filed 17 Jul 2024 | Generation Bio Co | SEC FORM 4 Code F | $1,442492 at $2.93 | filing |
| 15 Apr 2024filed 17 Apr 2024 | Generation Bio Cooption or derivative | SEC FORM 4 Code M | —1,674 at $0.00 | filing |
| 15 Apr 2024filed 17 Apr 2024 | Generation Bio Cooption or derivative | SEC FORM 4 Code M | —1,673 at $0.00 | filing |
| 15 Apr 2024filed 17 Apr 2024 | Generation Bio Co | SEC FORM 4 Code M | —1,674 | filing |
| 15 Apr 2024filed 17 Apr 2024 | Generation Bio Co | SEC FORM 4 Code F | $1,820492 at $3.70 | filing |
| 15 Apr 2024filed 17 Apr 2024 | Generation Bio Co | SEC FORM 4 Code M | —1,673 | filing |
| 15 Apr 2024filed 17 Apr 2024 | Generation Bio Co | SEC FORM 4 Code F | $1,820492 at $3.70 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.